ey0016.8-12 | New Genes | ESPEYB16
L Ben Aim , P Pigny , LJ Castro-Vega , A Buffet , L Amar , J Bertherat , D Drui , I Guilhem , E Baudin , C Lussey-Lepoutre , C Corsini , G Chabrier , C Briet , L Faivre , C Cardot-Bauters , J Favier , AP Gimenez-Roqueplo , N Burnichon
ey0016.9-15 | Biologic Agents and Growth in Chronic Inflammatory Diseases | ESPEYB16
KN Bharucha , HI Brunner , I Calvo Penades , I Nikishina , N Rubio-Perez , S Oliveira , K Kobusinska , H Schmeling , F Sztajnbok , F Weller-Heinemann , E Zholobova , F Zulian , R Allen , J Chaitow , J Frane , C Wells , N Ruperto , F De Benedetti
ey0018.13-7 | Endocrinology | ESPEYB18
K Armstrong , AB Yap , S Chan-Cua , ME Craig , C Cole , V Chi Dung , J Hansen , M Ibrahim , H Nadeem , A Pulungan , J Raza , A Utari , P. Ward
ey0017.3-14 | Thyroid cancer | ESPEYB17
RJ DeHoog , J Zhang , E Alore , JQ Lin , W Yu , S Woody , C Almendariz , M Lin , AF Engelsman , SB Sidhu , R Tibshirani , J Suliburk , LS Eberlin
ey0020.6-8 | New Hope | ESPEYB20
H Agnani , G Bachelot , T Eguether , B Ribault , J Fiet , Y Le Bouc , I Netchine , M Houang , A Lamaziere
ey0016.5-2 | New Therapies and Novel Therapeutic Strategies | ESPEYB16
F Zaman , Y Zhao , B Celvin , HH Mehta , J Wan , D Chrysis , C Ohlsson , B Fadeel , P Cohen , L Savendahl
ey0016.4-3 | Important for Clinical Practice | ESPEYB16
L Plachy , V Strakova , L Elblova , B Obermannova , S Kolouskova , M Snajderova , D Zemkova , P Dusatkova , Z Sumnik , J Lebl , S Pruhova
ey0019.12-11 | Hyperlipidemia | ESPEYB19
ey0020.13-4 | Section | ESPEYB20
LA Bergeron , S Besenbacher , J Zheng , P Li , MF Bertelsen , B Quintard , JI Hoffman , Z Li , J St Leger , C Shao , J Stiller , MTP Gilbert , MH Schierup , G Zhang
ey0015.8-12 | Clinical Trials – New Treatments | ESPEYB15
B Venkatesh , S Finfer , J Cohen , D Rajbhandari , Y Arabi , R Bellomo , L Billot , M Correa , P Glass , M Harward , C Joyce , Q Li , C McArthur , A Perner , A Rhodes , K Thompson , S Webb , J Myburgh